TCL Archive Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint March 29, 2013
TCL Archive NCI Proposes Inviting Academic Labs To Submit New Therapies For Development January 16, 1998
TCL Archive Cancer & The Media: Klausner, Watson Dispute Comments In New York Times Story May 8, 1998